XML 51 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Income Taxes
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
8.
INCOME TAXES
  
 
Income tax benefit increased
$3.4
million for the
three
months ended
March 31, 2020,
to a
$3.5
million income tax benefit as compared to an income tax benefit of
$0.1
million for the
three
months ended
March 31, 2019.
The Company’s effective tax rate benefit was
87%
and
4%
for the
three
months ended
March 31, 2020
and
2019,
respectively. The Company’s effective tax rate benefit increased in the
three
months ended
March 31, 2020,
as compared to the same period in
2019,
primarily due to a  favorable increase in excess tax benefits related to employee stock compensation and an income tax benefit recorded to carryback net operating losses (NOLs), pursuant to the provisions of Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) passed on
March 27, 2020,
which allows any federal net operating losses generated in years beginning after
December 31, 2017
and before
January 1, 2021
to be carried back up to
five
taxable years to offset taxable income in the prior periods. 
 
 
 
 
 
The Company’s total amount of unrecognized tax benefits, excluding interest and penalties, as of
March 31, 2020,
was
$13.0
 million, of which
$7.4
million, if recognized, would affect the Company’s effective tax rate. The Company’s total amount of unrecognized tax benefits, excluding interest and penalties, as of
December 31, 2019,
was
$13.6
million, of which
$7.9
million, if recognized, would affect the Company’s effective tax rate. As of
March 31, 2020,
the Company has recorded unrecognized tax benefits of 
$2.6
million, including interest and penalties of
$0.8
million, as long-term taxes payable in its Condensed Consolidated Balance Sheet. The remaining
$11.2
million has been recorded net of our deferred tax assets, of which
$5.6
 million is subject to a full valuation allowance. 
 
The valuation allowance was approximately
$10.0
million and
$10.5
million as of
March 31, 2020,
and
December 31, 2019,
respectively, which was related to California R&D tax credits and California net operating losses related to our acquisition of Syntricity that we currently do
not
believe are more likely than
not
to be ultimately realized.
  
The Company conducts business globally and, as a result, files numerous consolidated and separate income tax returns in the U.S. federal, various state and foreign jurisdictions. Because the Company used some of the tax attributes carried forward from previous years to tax years that are still open for audit, the federal and California statute of limitations remains open for all tax years since
1999
and
2002,
respectively. The Company is
not
currently subject to an income tax examination or under audit in any jurisdiction.